An intense 18F-FDG pulmonary microfocus on PET without detectable abnormality on CT: A manifestation of an iatrogenic FDG pulmonary embolus

INTRODUCTION

Positron Emission Tomography/Computed Tomography (PET/CT) fusion imaging is a novel multi-modality technology that allows the correlation of findings from two concurrent imaging modalities in a comprehensive examination. As altered glucose metabolism is characteristic for many malignancies, FDG-PET is mostly used in oncology for staging and therapy monitoring. It can also be seen as a physiologic activity in the bowel or muscles, in benign disease such as inflammation or post-traumatic reactive changes, or simply represent artefactual uptake from inaccurate CT attenuation correction in dense objects, often mistaken for cancer [1–3].

The experienced PET/CT reader mostly manages to differentiate malignant from non-malignant FDG uptake based on accurate interpretation of the PET data by correlating with the CT anatomic information [1–3]. This paper documents an example of a false positive PET/CT interpretation of an artefact, which may at times be erroneously diagnosed as a pathological entity.

CASE REPORT

This case report looks at a 61 year-old lady who has a history of nodal positive right breast cancer treated by surgery and chemotherapy in 1996. She was referred for a PET/CT in February 2007 with the query of locoregional recurrence because of recurrent chest wall pain. PET/CT study revealed an intense ¹⁸F-FDG focus in the apical segment of the left lower lobe on PET without any perceptible corresponding CT lesion (Figure 1). By virtue of the lesion-imperceptibility on the correlative CT, a provisional diagnosis of an iatrogenic FDG microembolus was made and the patient was managed conservatively. A follow-up PET/CT done seven months later demonstrated complete resolution of the PET abnormality and confirmed its benign aetiology (Figure 2).

Figure 1 Correlative axial images of CT (left) and PET (right) (February 2007): The PET image displayed an intense 18F-FDG focus in the apical segment of the left lower lobe which is imperceptible on the corresponding CT image. It has maximal SUV of 17.9 and an estimated maximal diameter of 2.5 cm.

Figure 2 Correlative axial images of CT (left) and PET (right) (September 2007): The previously documented focal FDG uptake in the left lung has resolved, likely to represent FDG microembolus rather than metastatic disease.

DISCUSSION

In this case, the intense ¹⁸F-FDG focus in the left lower lobe is highly suggestive of thromboembolus phenomenon attributed to a tagged platelet or mixed nature rather than red blood cells [3, 5]. This detected FDG activity was no longer apparent on the follow-up PET/CT done seven months later. Of late, there have been a number of similar reported cases and all the cases exhibited similar features on the PET/CT correlative images [1–3].

An intense ¹⁸F-FDG-PET focus without a detectable CT abnormality may rarely be a result of an early imperceptible structural lesion [1–4]. Complete resolution of such an intense FDG focus in all the known reported instances is, therefore, essential to establish the final diagnosis.

In principle, an intense FDG focus is not entirely specific for malignancy. In general, CT is more sensitive than FDG-PET in the detection of pulmonary lesions, given its superior spatial resolution [4]. Therefore the absence of structural lesions on CT alerts to the possibility that the focal FDG-PET intensity is not a genuine abnormality.

This is in line with the fact that more than one-third of scintigraphic equivocal lesions were correctly triaged by analysis of the morphological and anatomical details on the correlative CT study [4].

Incidence of microembolus formation involving radiotracer injection has also been reported in patients with abnormal peripheral venous system and difficult phlebotomy, following the usage of an old intravenous cannula, or the presence of a hypercoagulability state in which the FDG is mixed with blood products prior to injection [5]. The phenomenon may be reduced by using a new intravenous cannula, avoiding the withdrawal of blood prior to FDG injection and adopting a good intravenous technique.

CONCLUSION

An intense ¹⁸F-FDG-PET pulmonary abnormality without detectable lesions on the correlative CT study is highly suggestive of artefacts caused by FDG microembolus. This report emphasises the importance of becoming familiar with the potential pitfalls of false-positive interpretations of PET.

References

1. Hany TF, Heuberger J and von Schulthess GK. Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation. Eur Radiol 2003; 13(9):2122�2127.   [Medline]
   
2. Karantanis D, Subramaniam RM, Mullan BP, Peller PJ and Wiseman GA. Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT. J Comput Assist Tomogr 2007; 31(5):800�805.   [Medline]
   
3. Ha JM, Jeong SY, Seo YS, Kwon SY, Chong A, Oh JR, Song HC, Bom HS and Min JJ. Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings. Ann Nucl Med 2009; 23(6): 599�603.   [Medline]
   
4. Mester U and Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med 2007; 37(3):206�222.   [Medline]
   
5. Conca DM, Brill DR and Shoop JD. Pulmonary radioactive microemboli following radionuclide venography. J Nucl Med 1977; 18(11):1140�1141.   [Medline]